Bei Yang Ph.D.
About Bei Yang Ph.D.
Bei Yang, Ph.D., is the Director and Head of Clinpharm & Pharmacometrics at Bristol Myers Squibb, with extensive experience in clinical pharmacology and advanced PK/PD modeling.
Current Roles at Bristol Myers Squibb and Sanofi-Aventis
Bei Yang, Ph.D., serves as the Director, Head of Clinpharm & Pharmacometrics at Bristol Myers Squibb, where he leads teams involved in clinical pharmacology and pharmacometrics. Concurrently, he is also the Associate Director of Clinical Pharmacology at Sanofi-Aventis in Shanghai. His roles include overseeing and integrating clinical pharmacology strategies to optimize drug development processes.
Previous Professional Experience
Bei Yang has held multiple roles in the pharmaceutical industry. From 2017 to 2018, he worked at Luoxin Biotech in Shanghai as a Clinical Pharmacology Lead. He spent five years at Ann Arbor Pharmacometrics Group, serving as a pharmacometrician from 2012 to 2017. Earlier in his career, he gained industry experience through internships at Pfizer in Groton, CT in 2011 and Bristol-Myers Squibb in New Brunswick, NJ in 2008.
Educational Background
Bei Yang achieved a Ph.D. in Pharmaceutical Sciences from the University of Michigan between 2007 and 2012. He also holds an MA in Statistics from the same institution, earned from 2009 to 2011. Prior to his time at the University of Michigan, he completed an MS in Pharmaceutical Analysis from Fudan University (2004–2007) and a BS in Pharmacy from Fudan University (2000–2004).
Technical Expertise in Clinical Pharmacology
Bei Yang has a comprehensive skill set in clinical pharmacology, highlighted by his extensive experience in PK/PD modeling and simulations for clinical trials from Phase 1 to Phase 3. He is responsible for preparing technical documents for NDA filings and has practical experience in transporter and PK studies. Yang is proficient in radioactive assay and instrumental analysis, including HPLC, LC-MS, GC, and GC-MS.
Proficiency in Modeling and Statistical Software
Yang demonstrates expertise with pharmacokinetic/pharmacodynamic (PK/PD) and statistical modeling software. He is proficient in several industry-standard tools, including NONMEM, WinNonlin, R, S-plus, Gastroplus, and SAS. His technical proficiency supports his work in performing advanced PK/PD modeling and simulations across various therapeutic areas.